Medicine recalls
|
| |
| Canada: Recall: NRA-Quetiapine XR Tablet 50mg: Some lots exceed the intake limit of N-nitroso-desalkyl-quetiapine (NDAQ) |
| |
Health Canada announces that Nora Pharma Inc. is recalling 2 lots of NRA-Quetiapine XR Tablet 50mg (lot number: M2216571 and M2214003) from retailers because the affected lots may exceed the established acceptable intake limit for N-nitroso-desalkyl-quetiapine (NDAQ).
The product is indicated for the management of schizophrenia, bipolar disorder and major depressive disorder.
Please refer to the following website in Health Canada for details:
http://recalls-rappels.canada.ca/en/alert-recall/nra-quetiapine-xr-some-lots-exceed-intake-limit-n-nitroso-desalkyl-quetiapine-ndaq
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/Saturday, Apr 12, 2025
Issued at HKT 12:00
|
| |
